AIRLINK 196.51 Increased By ▲ 4.67 (2.43%)
BOP 10.07 Increased By ▲ 0.20 (2.03%)
CNERGY 7.81 Increased By ▲ 0.14 (1.83%)
FCCL 38.46 Increased By ▲ 0.60 (1.58%)
FFL 15.72 Decreased By ▼ -0.04 (-0.25%)
FLYNG 24.54 Decreased By ▼ -0.77 (-3.04%)
HUBC 130.10 Decreased By ▼ -0.07 (-0.05%)
HUMNL 13.70 Increased By ▲ 0.11 (0.81%)
KEL 4.60 Decreased By ▼ -0.07 (-1.5%)
KOSM 6.20 Decreased By ▼ -0.01 (-0.16%)
MLCF 45.05 Increased By ▲ 0.76 (1.72%)
OGDC 206.65 Decreased By ▼ -0.22 (-0.11%)
PACE 6.60 Increased By ▲ 0.04 (0.61%)
PAEL 39.70 Decreased By ▼ -0.85 (-2.1%)
PIAHCLA 17.15 Decreased By ▼ -0.44 (-2.5%)
PIBTL 7.98 Decreased By ▼ -0.09 (-1.12%)
POWER 9.12 Decreased By ▼ -0.12 (-1.3%)
PPL 179.40 Increased By ▲ 0.84 (0.47%)
PRL 38.51 Decreased By ▼ -0.57 (-1.46%)
PTC 24.20 Increased By ▲ 0.06 (0.25%)
SEARL 109.15 Increased By ▲ 1.30 (1.21%)
SILK 1.01 Increased By ▲ 0.04 (4.12%)
SSGC 37.78 Decreased By ▼ -1.33 (-3.4%)
SYM 18.80 Decreased By ▼ -0.32 (-1.67%)
TELE 8.51 Decreased By ▼ -0.09 (-1.05%)
TPLP 12.12 Decreased By ▼ -0.25 (-2.02%)
TRG 64.69 Decreased By ▼ -1.32 (-2%)
WAVESAPP 12.01 Decreased By ▼ -0.77 (-6.03%)
WTL 1.64 Decreased By ▼ -0.06 (-3.53%)
YOUW 3.87 Decreased By ▼ -0.08 (-2.03%)
BR100 12,000 Increased By 69.2 (0.58%)
BR30 35,548 Decreased By -112 (-0.31%)
KSE100 114,256 Increased By 1049.3 (0.93%)
KSE30 35,870 Increased By 304.3 (0.86%)

BEIJING: China on Friday said it would for the first time allow the general public to use rapid COVID-19 antigen tests that do not need medical workers to take samples as it steps up efforts to ensure infections are identified at an early stage.

In China’s latest and previous local outbreaks, many Chinese cities had tested tens of thousands of people after a handful of cases emerged.

That strategy could become more challenging as the daily rise in domestically-transmitted cases reached a two-year high for the country this week, as the highly contagious Omicron variant spreads and many carriers are asymptomatic.

WHO announces 2nd hub for training countries to make COVID vaccines

Antigen tests that can be used by individuals have helped to relieve testing bottlenecks in countries such Singapore and South Korea, while China, where case numbers remained relatively low, relied on nucleic acid tests that require medical professionals to take samples.

People under quarantine or lockdown will be able to use self-use antigen tests under supervision of the authorities, while other residents who need such tests will be able to buy kits in stores or online, the National Health Commission said on its website.

China has boosted its nucleic acid testing capacity in the last two years and those tests will continue to be used for diagnosis of those who test positive for COVID-19. Those who tested positive using antigen test and those negative but showing suspicious symptoms should still undergo nucleic acid tests.

Antigen test requirement scrapped for travellers to Dubai, Sharjah from Pakistan

Chinese authorities said in February that rapid antigen tests are allowed for staffers working on ships that arrive from abroad when nucleic acid tests are unavailable, without specifying whether those antigen tests could be used without medical workers taking samples or not.

Comments

Comments are closed.